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SUMMARY 
We were able to observe the effect of withdrawal of endogenous sympathetic 
drive in a hypertensive patient with an aldosterone-secreting adrenal adenoma. 
Acute stimulation of both carotid sinus nerves lowered blood pressure to 
normotensive or hypotensive levels by reducing peripheral resistance. When 
chronic carotid sinus nerve stimulation was discontinued, peripheral resistance 
and blood pressure increased. These data suggest that the sympathetic nervous 
system is important in the maintenance of hypertension in established primary 
aldosteronism. 
The pathogenesis of the hypertension in primary aldosteronism has intrigued and baffled 
researchers. Whereas there is evidence that the sympathetic nervous system may play a 
vital role in the development and maintenance of elevated pressures in one animal model 
of mineralocorticoid hypertension (DOCA-salt hypertension in rats), the possibility that 
a neurogenic component is important in the hypertension of human primary aldoster- 
onism has received scant study. We had the unique opportunity to document blood 
pressure and haemodynamic responses to withdrawal of endogenous sympathetic drive in 
a patient with primary aldosteronism. Our data show that sympathetic drive is not 
suppressed and suggest that sympathetic nervous activity contributes to the hypertension 
of primary aldosteronism. 
CASE REPORT 
The patient, a 47-year-old white male was first observed to have elevated blood pressure 
(1 50/90 mm Hg) in 1948 at  16 years of age. Drug treatment was initiated at 34 years when 
severe hypertension was documented (200/120 mm Hg). Blood pressure control was poor 
despite multiple therapeutic regimes, and drug-induced side effects were prominent. He 
complained of intermittent muscle weakness, and hypokalaemia (2.3-3.4 mmol/l) was 
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noted on a number of occasions, usually during thiazide treatment. Primary aldoster- 
onism was suspected but plasma renin results obtained in 1972 were difficult to interpret. 
One renin level was very low, but a second (397 ng 100 ml-' h-') was reported to be within 
normal limits. The second sample, however, was obtained while the patient's blood 
pressure was very high (220/140 mm Hg), and the renin-angiotensin system was being 
stimulated by the combination of a low sodium diet (10 mmol/day), upright body posture, 
and thiazide and hydralazine treatment. Aldosterone measurements were not obtained at 
this time. 
In view of the uncontrolled hypertension, the drug-related side effects, and in the 
absence of a definitive diagnosis of primary aldosteronism, consideration was given to 
attempt blood pressure control with chronic carotid sinus nerve stimulation. The 
experimental nature of the procedure was fully explained to the patient, and his consent 
was obtained. Ethical Committee approval was given for this procedure in otherwise 
uncontrollable hypertension. In February 1972, a Medtronic Barostat@ bilateral carotid 
sinus nerve stimulator was implanted (Schwartz et a/., 1967). Over the subsequent 6 years, 
blood pressure levels were considerably lowered (Fig. 1). Prolonged normalization of 
pressure was not possible only because the patient experienced an unpleasant sensation in 
the throat at high baropacer settings, thus diuretic (and supplementary potassium) 
therapy was required along with a low level of carotid sinus nerve stimulation. Between 
1972 and 1978, withdrawal of baropacer stimulation invariably resulted in the return of 
severe hypertension (Fig. I ) .  When the baropacer setting was temporarily increased, 
blood pressure regularly fell to hypotensive levels (less than 110/70 mm Hg, see Fig. 2). 
Baropacer Adrenalectomy 
Fig. I .  Blood pressure responses to bilateral carotid nerve stimulation (baropacer). and to 
unilateral adrenalectomy in a patient with primary aldosteronism. After 1970. blood pressure 
levels shown are the mean of at least three readings. Multiple combined drug regimes were used 
prior to baropacer insertion, diuretic and potassium treatment was generally required during the 
period of baropacer stimulation, and a combination of diuretic and alpha methyldopa therapy 
was exhibited after adrenalectomy. The lower panel represents the rise in mean blood pressure 





Fig. 2. Haemodynamic responses to bilateral carotid sinus nerve stimulation in a patient with 
primary aldosteronism during thiazide diuretic and supplemental potassium therapy, The patient 
was supine during this study. Cardiac output wasmeasured following the injection of indocyanine 
green. *Resistance index is in arbitrary units (=mean arterial pressure/cardiac index). 
Haemodynamic studies performed in 1972 (Fig. 2), and repeated in 1973, showed that 
baropacer stimulation lowered supine blood pressure primarily by reducing peripheral 
resistance, although pulse rate and cardiac index also fell somewhat. These changes were 
reversed when the baropacer was switched off (Fig. 2). 
An intermittent electrical malfunction developed from 1975 which necessitated an 
increase in antihypertensive medication. However, when functioning correctly, baropacer 
stimulation continued to reduce blood pressure, often to hypotensive levels. 
In 1978, the baropacer was switched off, medications were stopped, and treatment with 
the oral converting enzyme inhibitor captopril(l50 mg three times daily) was initiated in 
the Clinical Research Center at the University of Michigan Hospital. Blood pressure rose 
to 180/125 mm Hg. Addition of hydrochlorothiazide had little effect on the blood 
pressure but serum potassium fell to 1.9 mmol/l. The diagnosis of primary aldosteronism 
was again entertained, and was confirmed when plasma renin activity (Haber et al., 1969) 
and angiotensin I1 levels (Nicholls & Espiner, 1976) were found to be low, and serum 
aldosterone levels (Antunes et al., 1976) did not decline during a high sodium intake 
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Table I .  Plasma hormone and electrolyte indices (1978)' 
Serum 
PRA Angiotensin I1 Aldosterone Sodium Potassium 
(rig. ml-*. h-') (pg/ml) (ng/100 ml) (mmol/l) (mmolil) 
3 days high sodium diet: 
(Na 200 mmmoliday. 
K 100 mmoliday) 
Supine < 0.0 1 1 5  36.2 148 2.8 
Upright 1 h 1 0.0 1 1 5  27.5 142 3.2 
Upright 4 h <0.01 < 5  27.6 143 3.1 
4 days low sodium diet: 
(Na 10 mmol/day. 
K 100 mmoliday) 
Supine 0.08 < 5  26.4 145 3.4 
Upright 2 h 0.13 1 5  27.1 142 3.7 
Upright 4 h 0.04 1 5  23.7 I42 3.7 
* The patient was receiving supplemental oral potassium as the only medication for 2 weeks 
Conversion to SI units: PRA 1 ng. ml- ' .  h-'=0.77 nmol. I - ' .  h k ' .  Angiotensin 11 1 
before studies. 
pg/ml= 0.95 pmolil. Aldosterone 1 ng/100 ml= 27.8 pmol/l. 
(Table I). Urine aldosterone excretion (Bayard ef al., 1970) measured during the high 
sodium intake was elevated at 82.5 c(g/24 h (normal 2-15 pg/24 h). 
Bilateral adrenal vein sampling and venography, together with iodocholesterol adrenal 
scanning suggested a single adenoma on the left, which was confirmed at unilateral 
adrenalectomy in January 1979. Two months after surgery urine aldosterone was normal 
(1 1.2 pg/24 h), as was his ambulatory plasma renin (2.5 ng. mI.-' h-', urine sodium 127 
mmol/24 h). Although his blood pressure was slightly elevated at  this time 
(140/88-168/104 mm Hg), it was considerably lower than in previous years (Fig. 1) and 
was returned to normal by hydrochlorothiazide and a methyldopa therapy. The patient's 
vigour and well-being were dramatically improved following unilateral adrenalectomy . 
DISCUSSION 
The pathogenesis of the hypertension in primary aldosteronism is unclear. It is probable 
that there is a complex interplay of a number of mechanisms, and that these factors differ 
in importance at the developmental and the maintenance phases of the hypertension. 
Involvement of the sympathetic nervous system in one model of mineralocorticoid 
hypertension, the DOCA-salt uninephrectomized rat, has been extensively studied. 
Although interpretation of this literature is open to debate (Louis et al., 1970), the data 
strongly suggest an important role for the sympathetic nervous system in this type of 
hypertension. Specifically, studies in this model have documented an increase in 
norepinephrine turnover in many organs including the heart (de Champlain et al., 1969), 
raised circulating norpinephrine levels (Reid et af., 1975; de Champlain et af., 1976), 
enhanced pressor responsiveness to administered norepinephrine (Beilin et af., 1970), 
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increased sympatho-adrenal activity (Grobecker et al., 1976) and return of blood 
pressure to normal following either destruction of central catecholinergic neurons (Reid 
et al., 1975) or combined chemical sympathectomy and bilateral adrenalectomy (de 
Champlain & van Ameringen, 1972). 
A possible pathogenic role for the sympathetic system in human mineralocorticoid 
hypertension has received less attention. During the developmental phase of the 
hypertension, pulse rate is slowed (Nicholls et al., 1979) and plasma norepinephrine levels 
fall (Distler et al.,  1979), perhaps reflecting a reduction of sympathetic drive at this initial 
stage. The hypertension of established primary aldosteronism may be hyperkinetic 
(Tarazi et al., 1973), which would be consistent with there being an active sympathetic 
nervous system at this phase. On the contrary, there are data suggestive of a reduced 
adrenergic state in primary aldosteronism (Biglieri & McIlroy, 1966; Distler et al., 1970). 
The present case study shows that withdrawal of endogenous sympathetic drive by 
stimulation of a physiological pathway (the carotid sinus baroreceptor nerves) is capable 
of returning blood pressure to normal in a patient with established primary aldoster- 
onism. Although anecdotal, this finding has important implications. First, it is evident 
that unlike the renin-angiotensin system, sympathetic nervous activity was not com- 
pletely suppressed in our patient. Secondly, in that withdrawal of endogenous sympathe- 
tic tone was capable of lowering blood pressure into and below normotensive levels, it is 
likely that the sympathetic nervous system at least contributed to the maintenance of the 
hypertension. 
The hypertension in established primary aldosteronism is maintained largely by a high 
peripheral resistance (Tarazi et al., 1973). In the present case, withdrawal of endogenous 
sympathetic drive returned blood pressure to normal primarily by reducing peripheral 
resistance. Thus, sympathetic nervous system activity was contributing to the underlying 
haemodynamic abnormality, i.e. the elevated vascular resistance. 
The present data do not allow the conclusion that sympathetic nervous system activity 
is increased in established primary aldosteronism. Nevertheless, even a ‘normal’ level of 
sympathetic function may be important along with other factors, such as hypervolaernia, 
in determining the degree of hypertension in these patients. 
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